RUNNYMEDE MEDICAL PRACTICE — All Prescriptions & Medications — Page 7
Practice Code: H81047 | EGHAM, TW20 0PF
Showing results 301-350 of 609
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Biphasic isophane insulin | 72 | 458 | £2.3K | -35.5% ▼ |
| Powder amino acid formula (0913107) | 72 | 390.0K | £24.5K | +118.1% ▲ |
| Emollient bath and shower preparations | 72 | 36.3K | £438 | +14.6% ▲ |
| Betamethasone esters | 71 | 4,140 | £516 | +17.7% ▲ |
| Oxcarbazepine | 70 | 1,656 | £437 | +150.3% ▲ |
| Metronidazole | 70 | 1,159 | £148 | +6.5% ▲ |
| Nicorandil | 69 | 10.1K | £1.4K | -52.1% ▼ |
| Alfacalcidol | 68 | 4,440 | £523 | -45.0% ▼ |
| Etoricoxib | 68 | 3,416 | £1.1K | -15.6% ▼ |
| Miconazole nitrate | 68 | 2,640 | £427 | -3.9% ▼ |
| Duloxetine hydrochloride | 67 | 3,122 | £661 | +30.7% ▲ |
| Terbinafine hydrochloride | 66 | 3,682 | £1.5K | +6.8% ▲ |
| Chlorpromazine hydrochloride | 65 | 910 | £1.0K | +65.3% ▲ |
| Combined ethinylestradiol 20mcg | 65 | 3,275 | £1.1K | +24.4% ▲ |
| Amiodarone hydrochloride | 64 | 1,148 | £69 | -0.8% vs avg |
| Empagliflozin/metformin | 64 | 7,576 | £4.7K | +22.9% ▲ |
| Methenamine hippurate | 63 | 6,976 | £1.8K | -30.7% ▼ |
| Medroxyprogesterone acetate | 63 | 63 | £351 | -47.8% ▼ |
| Coal tar | 63 | 18.6K | £468 | -13.5% ▼ |
| Orlistat | 62 | 5,796 | £1.4K | -24.8% ▼ |
| Fentanyl | 62 | 635 | £1.7K | -39.5% ▼ |
| Water for injection | 62 | 670 | £214 | +83.3% ▲ |
| 62 | 62 | £144 | +91.3% ▲ | |
| Cinnarizine | 61 | 5,450 | £250 | +30.4% ▲ |
| Triamcinolone acetonide | 61 | 72 | £100 | -18.5% ▼ |
| Insulin detemir | 60 | 400 | £3.4K | -23.4% ▼ |
| Dutasteride | 60 | 2,788 | £167 | +16.9% ▲ |
| Mycophenolate mofetil | 60 | 10.4K | £3.2K | +48.2% ▲ |
| Acetazolamide | 60 | 4,314 | £168 | +176.9% ▲ |
| Neomycin sulfate | 60 | 945 | £120 | +1.2% vs avg |
| 60 | 630 | £81 | +59.6% ▲ | |
| Levodopa/carbidopa/entacapone | 59 | 4,256 | £2.8K | +111.0% ▲ |
| Denosumab | 59 | 59 | £10.8K | +116.8% ▲ |
| Tibolone | 58 | 1,372 | £130 | +89.5% ▲ |
| Atomoxetine hydrochloride | 57 | 2,548 | £5.2K | +68.6% ▲ |
| Mefenamic acid | 57 | 3,917 | £740 | +26.2% ▲ |
| 57 | 6,600 | £601 | +20.7% ▲ | |
| Valsartan | 56 | 3,864 | £848 | -4.9% ▼ |
| Terbutaline sulphate | 56 | 79 | £624 | +3.3% ▲ |
| Lormetazepam | 56 | 392 | £133 | +375.5% ▲ |
| Reboxetine | 56 | 616 | £191 | +263.6% ▲ |
| Methylprednisolone acetate | 54 | 61 | £197 | -53.2% ▼ |
| Ketoconazole | 54 | 7,080 | £1.0K | -45.0% ▼ |
| Ticagrelor | 53 | 4,648 | £4.5K | -37.7% ▼ |
| Atropine sulfate | 53 | 750 | £8.1K | +316.0% ▲ |
| 53 | 5,200 | £348 | -24.0% ▼ | |
| 53 | 7,850 | £949 | +198.4% ▲ | |
| Primidone | 52 | 156 | £126 | +46.1% ▲ |
| Biphasic insulin aspart | 52 | 510 | £3.0K | -48.8% ▼ |
| 52 | 3,440 | £11.7K | +38.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.